Indraprastha Medical Corporation Ltd Stock Price Today (NSE: INDRAMEDCO)
Fundamental Score
Indraprastha Medical Corporation Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Indraprastha Medical Corporation Ltd share price today is ₹372.35, down 4.91% on NSE/BSE as of 30 March 2026. Indraprastha Medical Corporation Ltd (INDRAMEDCO) is a Small-cap company in the Hospital sector with a market capitalisation of ₹4.62K (Cr). The 52-week high for INDRAMEDCO share price is ₹640.85 and the 52-week low is ₹321.95. At a P/E ratio of 26.44x, INDRAMEDCO is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 30.04% and a debt-to-equity ratio of 0.05.
Indraprastha Medical Corporation Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Indraprastha Medical Corporation Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Indraprastha Medical Share Price
The hospital sector, increasingly driven by specialized treatments and an aging population, presents both opportunities and challenges for investors. This analysis focuses on the recent performance of Indraprastha Medical share price, currently trading at ₹378.5, within this evolving landscape. The company exhibits a Price-to-Earnings (PE) ratio of 26.44 and a Return on Capital Employed (ROCE) of 39.1%. This report forms part of a comprehensive, 80-parameter fundamental audit, meticulously verified by Sweta Mishra.
A crucial aspect of evaluating any healthcare provider is comparing its operational efficiency with its peers. When we contrast Indraprastha Medical Corporation Ltd with peers like
Nephro Care India Limited, assessing the quality of management becomes paramount. This assessment involves analyzing factors such as strategic decision-making, corporate governance, and the track record of capital allocation. Superior management often translates to improved operational performance and higher profitability, leading to greater shareholder value. Observations suggest that efficient management practices could be a significant differentiating factor in this sector.Indraprastha Medical's impressive ROCE of 39.1% deserves specific attention. ROCE measures how effectively a company uses its capital to generate profits. A high ROCE, such as the one observed, often indicates a strong competitive advantage or "moat." This means Indraprastha Medical is highly efficient in generating returns from its investments, potentially making it more resilient to economic downturns and competitive pressures. This efficiency could stem from factors like specialized service offerings, strong brand reputation, or efficient operational processes.
While the PE ratio of 26.44 offers a snapshot of the current valuation relative to earnings, a more holistic view requires examining other financial metrics and qualitative factors. These factors can include debt levels, cash flow generation, expansion plans, and the regulatory environment. In conclusion, Indraprastha Medical share price performance reflects a combination of its operational efficiency, as highlighted by the ROCE, and its relative valuation, as indicated by the PE ratio. Further investigation across all 80 parameters is recommended for a more complete understanding.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indraprastha Medical Corporation Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDRAMEDCO across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (30.04%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (39.10%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 26.44 vs Industry: 52.84)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Excellent EPS Growth (29.45% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (29.45% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (39.18x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹421.74 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (51.00%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 5.92%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Indraprastha Medical Corporation Ltd Financial Statements
Comprehensive financial data for Indraprastha Medical Corporation Ltd including income statement, balance sheet and cash flow
About INDRAMEDCO (Indraprastha Medical Corporation Ltd)
Indraprastha Medical Corporation Ltd is a beacon of advanced healthcare nestled in the heart of India, a sprawling complex dedicated to healing and wellness. The hospital's archite...cture blends seamlessly with verdant landscaping, offering patients and visitors a tranquil environment conducive to recovery. Inside, a network of brightly lit corridors connects state-of-the-art diagnostic centers with comfortable, private patient rooms. The air hums with quiet efficiency, a testament to the dedicated team of medical professionals working tirelessly. The aroma of freshly prepared meals wafts from the dietary services, while the gentle murmur of conversations creates a sense of community, reassuring patients that they are not alone on their journey to restored health. INDRAMEDCO distinguishes itself through its unwavering commitment to cutting-edge technology and specialized medical expertise. It houses a vast array of specialized units, each staffed with highly skilled physicians, nurses, and technicians. From the precision of robotic surgery suites to the advanced imaging capabilities of the radiology department, every resource is geared towards providing accurate diagnoses and effective treatments. The hospital boasts specialized clinics dedicated to addressing a wide spectrum of medical needs, ranging from intricate cardiovascular procedures to delicate neurological interventions. Its commitment to research and innovation drives it to continuously refine its treatment protocols, ensuring patients receive the best care. Beyond its impressive medical capabilities, INDRAMEDCO fosters a patient-centric culture rooted in compassion and empathy. The staff is trained to not only address the physical ailments of patients but also to provide emotional support and understanding. Warm smiles and attentive listening are integral parts of the healing process, creating a sense of trust and connection. INDRAMEDCO also emphasizes preventative care, with programs designed to promote healthy lifestyles and reduce the risk of chronic diseases. This holistic approach to healthcare, combined with its commitment to medical excellence, makes INDRAMEDCO a trusted name in healthcare.
Company Details
Key Leadership
Corporate Events
INDRAMEDCO Share Price: Frequently Asked Questions
What is the current share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
As of 30 Mar 2026, 12:07 pm IST, Indraprastha Medical Corporation Ltd share price is ₹372.35. The INDRAMEDCO stock has a market capitalisation of ₹4.62K (Cr) on NSE/BSE.
Is INDRAMEDCO share price Overvalued or Undervalued?
INDRAMEDCO share price is currently trading at a P/E ratio of 26.44x, compared to the industry average of 52.84x. Based on this relative valuation, the Indraprastha Medical Corporation Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of INDRAMEDCO share price?
The 52-week high of INDRAMEDCO share price is ₹640.85 and the 52-week low is ₹321.95. These values are updated daily from NSE/BSE price data.
What factors affect the Indraprastha Medical Corporation Ltd share price?
Key factors influencing INDRAMEDCO share price include quarterly earnings growth (Sales Growth: 8.92%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Indraprastha Medical Corporation Ltd a good stock for long-term investment?
Indraprastha Medical Corporation Ltd shows a 5-year Profit Growth of 29.45% and an ROE of 30.04%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.05 before investing in INDRAMEDCO shares.
How does Indraprastha Medical Corporation Ltd compare with its industry peers?
Indraprastha Medical Corporation Ltd competes with major peers in the Hospital. Investors should compare INDRAMEDCO share price P/E of 26.44x and ROE of 30.04% against the industry averages to determine competitive standing.
What is the P/E ratio of INDRAMEDCO and what does it mean?
INDRAMEDCO share price has a P/E ratio of 26.44x compared to the industry average of 52.84x. Investors pay ₹26 for every ₹1 of annual earnings.
How is INDRAMEDCO performing according to Bull Run's analysis?
INDRAMEDCO has a Bull Run fundamental score of 60/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does INDRAMEDCO belong to?
INDRAMEDCO operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Indraprastha Medical Corporation Ltd share price.
What is Return on Equity (ROE) and why is it important for INDRAMEDCO?
INDRAMEDCO has an ROE of 30.04%, which indicates excellent management efficiency. ROE measures how efficiently Indraprastha Medical Corporation Ltd generates profits from shareholders capital.
How is INDRAMEDCO debt-to-equity ratio and what does it indicate?
INDRAMEDCO has a debt-to-equity ratio of 0.05, which indicates conservative financing with low financial risk.
What is INDRAMEDCO dividend yield and is it a good dividend stock?
INDRAMEDCO offers a dividend yield of 0.89%, meaning you receive ₹0.89 annual dividend for every ₹100 invested in Indraprastha Medical Corporation Ltd shares.
How has INDRAMEDCO share price grown over the past 5 years?
INDRAMEDCO has achieved 5-year growth rates of: Sales Growth 10.30%, Profit Growth 29.45%, and EPS Growth 29.45%.
What is the promoter holding in INDRAMEDCO and why does it matter?
Promoters hold 51.00% of INDRAMEDCO shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Indraprastha Medical Corporation Ltd.
What is INDRAMEDCO market capitalisation category?
INDRAMEDCO has a market capitalisation of ₹4620 crores, placing it in the Small-cap category.
How volatile is INDRAMEDCO stock?
INDRAMEDCO has a beta of N/A. A beta > 1 suggests the Indraprastha Medical Corporation Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is INDRAMEDCO operating profit margin trend?
INDRAMEDCO has a 5-year average Operating Profit Margin (OPM) of 14.46%, indicating the company's operational efficiency.
How is INDRAMEDCO quarterly performance?
Recent quarterly performance shows Indraprastha Medical Corporation Ltd YoY Sales Growth of 8.92% and YoY Profit Growth of 16.65%.
What is the institutional holding pattern in INDRAMEDCO?
INDRAMEDCO has FII holding of 2.41% and DII holding of 3.51%. Significant institutional holding often suggests professional confidence in the Indraprastha Medical Corporation Ltd stock.